Spillover effects of the COVID-19 pandemic on attitudes to influenza and childhood vaccines.
COVID-19
Perceived risk
Perceived safety
Vaccinations
Vaccine attitudes
Vaccine hesitancy
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
25 04 2023
25 04 2023
Historique:
received:
16
01
2023
accepted:
11
04
2023
medline:
27
4
2023
pubmed:
26
4
2023
entrez:
25
4
2023
Statut:
epublish
Résumé
The current study sought to determine whether public perceptions of other vaccines and diseases than COVID-19 have been impacted by the COVID-19 pandemic. We longitudinally examined whether there had been a change from before the COVID-19 pandemic to during the pandemic in: (a) influenza vaccination behaviour and intentions; (b) the perceived benefit of childhood vaccines and influenza vaccines; (c) the perceived safety of childhood vaccines and influenza vaccines; (d) the perceived severity of measles and influenza; and (e) trust in healthcare professionals in two samples of Finnish adults (N = 205 in Study 1 and N = 197 in Study 2). The findings showed that during the pandemic, more people than before had received or wanted to receive the influenza vaccine. The respondents also believed that influenza was more dangerous during the pandemic and that vaccinations were safer and more beneficial. On the other hand, for childhood vaccines only perceived safety increased. Finally, in one of the studies, people had more confidence in medical professionals during the pandemic than they had before. Together, these findings imply a spillover of the COVID-19 pandemic on how people view other vaccines and illnesses.
Identifiants
pubmed: 37098527
doi: 10.1186/s12889-023-15653-4
pii: 10.1186/s12889-023-15653-4
pmc: PMC10126550
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
764Informations de copyright
© 2023. The Author(s).
Références
Pers Individ Dif. 2022 Feb;185:111295
pubmed: 34629582
Vaccine. 2014 Jul 7;32(32):4075-81
pubmed: 24877764
Lancet Glob Health. 2021 May;9(5):e590-e592
pubmed: 33667404
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Scand J Public Health. 2022 Jun;50(4):490-496
pubmed: 33845701
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Global Health. 2021 Jan 5;17(1):4
pubmed: 33402169
Vaccine. 2022 Nov 28;40(50):7262-7269
pubmed: 36333226
Lancet Digit Health. 2021 Mar;3(3):e175-e194
pubmed: 33518503
PLoS One. 2021 Apr 16;16(4):e0250123
pubmed: 33861765
JAMA. 2021 Jun 15;325(23):2397-2399
pubmed: 34028495
Sci Data. 2020 Aug 27;7(1):285
pubmed: 32855430
PLoS One. 2022 Feb 9;17(2):e0262823
pubmed: 35139103
J Pediatr. 2021 Jan;228:87-93.e2
pubmed: 32771480
J Community Health. 2022 Feb;47(1):39-52
pubmed: 34297272
Int J Epidemiol. 2018 Feb 1;47(1):15-16j
pubmed: 29025073
Lancet. 2023 Jan 7;401(10370):75-78
pubmed: 36309017
J Am Stat Assoc. 1948 Dec;43(244):572-4
pubmed: 18123073
Front Public Health. 2022 Aug 04;10:903557
pubmed: 35991061
Influenza Other Respir Viruses. 2021 May;15(3):407-412
pubmed: 33128444
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43
pubmed: 29855798